Precision volumetric concentration calculations are essential for reproducing standardized dosing regimens in preclinical research involving synthetic melanocortin analogs. This guide details the mathematical equations, reconstitution parameters, and quality metrics required to calculate exact microgram-per-volume concentrations of Melanotan 2 for laboratory research use.
Precision volumetric concentration calculations are essential for reproducing standardized dosing regimens in preclinical research involving synthetic melanocortin analogs. This guide details the mathematical equations, reconstitution parameters, and quality metrics required to calculate exact microgram-per-volume concentrations of Melanotan 2 for laboratory research use.
A Melanotan 2 dosage calculator is a volumetric reconstitution tool used by laboratory researchers to determine the precise microgram concentration of dissolved peptide per unit volume (mL or IU). By dividing the total lyophilized mass (e.g., 10 mg) by the added volume of sterile diluent (e.g., 2 mL), researchers calculate working concentrations (e.g., 500 mcg per 0.1 mL) for benchtop assays.
In cell culture models and preclinical animal studies, accurate volumetric concentration determines reproducible target receptor activation without solvent toxicity or aggregate formation. Calculating accurate concentrations allows laboratory technicians to deliver exact microgram quantities to microplate wells or research models while maintaining consistent solvent-to-analyte ratios across identical experimental cohorts. All calculations outlined in this guide are strictly intended for quantitative laboratory calculations, cell culture administration, and non-human animal study design.
Melanotan 2 (Melanotan II, MT-2) is a synthetic, cyclic heptapeptide analog of the endogenous alpha-melanocyte-stimulating hormone (α-MSH). Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, Melanotan 2 features a lactam bridge structure between the Asp and Lys residues, granting significantly higher enzymatic stability against carboxypeptidases compared to native linear α-MSH peptides.
Preclinical binding affinity assays demonstrate that Melanotan II acts as a potent non-selective agonist across central and peripheral melanocortin receptors, displaying affinity for MC1R, MC3R, MC4R, and MC5R. The compound is primarily studied for its potent melanocortin activity related to skin pigmentation responses in preclinical tissue models, as well as central metabolic and neuro-signaling cascades mediated by MC4R activation. Detailed structure-activity relationship (SAR) data can be reviewed in the PX1 research library.
In vitro data indicate that activation of the melanocortin 1 receptor (MC1R) by synthetic analogs initiates a cyclic adenosine monophosphate (cAMP) signaling cascade within follicular and epidermal melanocytes. This intracellular signaling cascade upregulates transcription factors such as microphthalmia-associated transcription factor (MITF), subsequently driving the transcription of tyrosinase, tyrosinase-related protein 1 (TRP-1), and dopachrome tautomerase (TRP-2). These enzymes catalyze the biotransformation of L-tyrosine into eumelanin polymers.
Preclinical rodent studies suggest that Melanotan 2 exhibits a significantly prolonged biological half-life relative to endogenous α-MSH due to its cyclic core. Research models evaluating skin pigmentation responses record measurable increases in melanin density following low nanomolar exposure in tissue explants. Experimental protocols involving all research peptides in the melanocortin class require meticulous microgram tracking, as receptor saturation and desensitization dynamics vary significantly based on concentration thresholds.
When designing comparative pharmacological assays, researchers frequently evaluate Melanotan 2 alongside other structural analogs within the melanocortin family. Differences in receptor selectivity, sequence cyclization, and lipophilicity alter both volumetric dilution targets and functional cellular endpoints across distinct experimental assays.
For example, Melanotan 1 research focuses on Afamelanotide, a linear synthetic analog that displays higher relative selectivity for MC1R over central MC4R subtypes compared to MT-2. In contrast, researchers studying central pathway signaling and physiological responses often contrast MT-2 with PT-141 (Bremelanotide), a metabolite derivative of Melanotan 2 engineered specifically to isolate MC3R and MC4R CNS pathways. Furthermore, anti-inflammatory downstream pathways of MSH fragments are studied using smaller tripeptide structures such as the KPV peptide, which acts through non-classical anti-inflammatory signaling rather than traditional melanogenic pathways.
To calculate working microgram concentrations from a solid lyophilized powder, researchers apply basic volumetric dilution equations based on mass concentration (C = m / V). Converting mass from milligrams (mg) to micrograms (mcg) is the first step: 1 mg equals 1,000 mcg. Therefore, a standard 10 mg vial of high-purity Melanotan 2 contains exactly 10,000 mcg of active peptide sequence.
When reconstituted with 2.0 mL of bacteriostatic water or sterile phosphate-buffered saline (PBS), the resulting primary stock concentration is calculated as 10,000 mcg divided by 2.0 mL, yielding 5,000 mcg/mL. To determine the microgram mass per single graduation unit on a 100-unit (1.0 mL) laboratory volumetric syringe, divide the total volume concentration by 100: 5,000 mcg/mL divided by 100 units equals 50 mcg per unit. If 1.0 mL of diluent is used instead, the concentration doubles to 10,000 mcg/mL, yielding 100 mcg per unit volume.
The following matrix outlines common volumetric reconstitution parameters for a standard 10 mg vial of Melanotan 2 reconstituted with bacteriostatic water for laboratory research use:
• Reconstitution Volume 1.0 mL: Final concentration = 10 mg/mL (10,000 mcg/mL). Volumetric yield: 100 mcg per 0.01 mL (1 IU unit). • Reconstitution Volume 2.0 mL: Final concentration = 5 mg/mL (5,000 mcg/mL). Volumetric yield: 50 mcg per 0.01 mL (1 IU unit). • Reconstitution Volume 2.5 mL: Final concentration = 4 mg/mL (4,000 mcg/mL). Volumetric yield: 40 mcg per 0.01 mL (1 IU unit). • Reconstitution Volume 5.0 mL: Final concentration = 2 mg/mL (2,000 mcg/mL). Volumetric yield: 20 mcg per 0.01 mL (1 IU unit).
For specialized in vitro bioassays requiring nanomolar working concentrations, primary stock solutions should be further diluted into culture media or saline using secondary serial dilutions as described in our peptide reconstitution guide.
Lyophilized Melanotan 2 is supplied as a trifluoroacetate (TFA) salt cake and demonstrates high solubility in aqueous buffer systems. For multi-use laboratory bench protocols spanning multiple days, reconstitution with 0.9% benzyl alcohol preserved water (bacteriostatic water) prevents microbial growth during repeated pipette tip sampling.
When introducing diluent into the glass vial, direct the liquid stream against the inner glass wall rather than spraying directly onto the lyophilized powder mass. Allow the diluent to gently wet the cake, then gently swirl the vial until complete dissolution is observed. Rapid agitation, mechanical vortexing, or violent shaking must be avoided, as shear stress can cause peptide denaturing or formation of insoluble sub-visible aggregates that alter calculated microgram concentrations.
Unreconstituted lyophilized Melanotan 2 powder should be stored long-term in a laboratory freezer at -20°C or -80°C, sealed with a desiccant to prevent moisture absorption. Under these conditions, high-purity lyophilized peptide remains stable for up to 24 months without significant degradation.
Once reconstituted into an aqueous working solution, the peptide should be stored at 2°C to 8°C and used within 28 days if preserved with bacteriostatic agents. For long-term storage of reconstituted solutions, researchers should aliquot the stock into single-use polypropylene microtubes and store them at -20°C to eliminate repeated freeze-thaw cycles, which degrade peptide integrity over time.
Experimental reproducibility relies entirely on verified peptide purity and exact net peptide content. PX1 Research subjects every batch of synthetic Melanotan 2 to dual analytical verification using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS) performed by independent ISO 17025 accredited analytical laboratories.
RP-HPLC verifies chemical purity by separating structural impurities, truncated sequences, and oxidation products, ensuring a minimum purity of 99%. Mass spectrometry confirms exact molecular mass against the theoretical chemical weight (1024.2 g/mol). Furthermore, all PX1 lots undergo quantitative chromogenic LAL assays to ensure strict endotoxin testing standards are met (<0.5 EU/mg), eliminating confounding inflammatory artifacts in preclinical models.
PX1 Research is an established USA-based manufacturer providing analytical-grade research compounds exclusively for qualified academic, institutional, and private laboratory facilities. All compounds are manufactured in domestic GMP-compliant facilities and shipped direct from fulfillment centers in California and Arizona with same-day dispatch for orders placed before daily cutoff times.
Every product shipment includes lot-specific Certificate of Analysis (COA) documents displaying raw HPLC chromatograms, mass spectra, and quantitative endotoxin test results. University departments and corporate laboratories requiring bulk quantities can apply for simplified procurement through our wholesale lab accounts portal to secure dedicated lot reservation and volume pricing.
How do you calculate the concentration of Melanotan 2 after reconstitution?
Divide the total mass of the lyophilized peptide in micrograms (e.g., 10 mg = 10,000 mcg) by the volume of diluent added in milliliters (e.g., 2 mL). This yields a concentration of 5,000 mcg/mL. Dividing by the volume unit allows researchers to measure exact microgram quantities for experimental assays.
What is the recommended diluent for reconstituting Melanotan 2 in a research setting?
Bacteriostatic water (0.9% benzyl alcohol) is standard for multi-use laboratory stock solutions stored up to 28 days at 2-8°C. Sterile 0.9% sodium chloride or phosphate-buffered saline (PBS) is preferred for immediate cell culture or single-day in vitro assays where preservatives might interfere with cell viability.
Why is lot-specific endotoxin testing critical for Melanotan 2 research?
Bacterial endotoxins (LPS) trigger non-specific inflammatory signaling and cytokine release in cell cultures and animal models. Low endotoxin levels (<0.5 EU/mg) ensure that observed biological responses are driven exclusively by melanocortin receptor activation rather than immune contaminants.
How does Melanotan 2 differ structurally from native alpha-MSH?
Native α-MSH is a linear 13-amino acid peptide, whereas Melanotan 2 is a shortened, cyclic heptapeptide containing a lactam ring between Asp and Lys. This cyclic structure protects the peptide from enzymatic cleavage, resulting in enhanced stability and receptor potency.
What storage conditions maintain Melanotan 2 peptide stability?
Lyophilized powder should be kept sealed with desiccant at -20°C for long-term stability. Reconstituted aqueous solutions should be kept refrigerated at 2-8°C and protected from light. Micro-aliquoting at -20°C prevents degradation caused by repeated freeze-thaw cycles.
What analytical methods verify the purity of PX1 Research peptides?
PX1 Research utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination (>99%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm sequence identity and molecular weight, validated by third-party ISO 17025 laboratories.
Can Melanotan 2 dosage calculators be applied to human clinical administration?
No. Volumetric concentration calculations provided by PX1 Research are intended strictly for laboratory reconstitution, analytical benchtop assays, and preclinical animal research models. PX1 products are not for human consumption, therapy, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.